A review of drug release mechanisms from nanocarrier systems.

The most common methods used for drug administrations are pills, injections, lotions and suppositories. The preferred means is oral dosage forms as it is simple, painless and self-administered. However, the drugs are usually degraded within gastrointestinal tract or not absorbed in sufficient quality to be effective. Over the years, a variety of other administration means have evolved to show specific advantages for particular agents and certain diseases. In this review, various nano-delivery systems consisting of different covalent linkages to conjugate the therapeutic molecules as well as those that carry the unmodified drug molecules by encapsulating or complexation are summarized, including ester, amide/peptide, disulfide, hydrazone, hypoxia-activated and self-immolative linkages. The mechanisms for controlled drug release are also discussed. In addition, the new mechanism of the recently developed photochemistry or thermolysis to trigger controlled drug release and the applications are also covered.

[1]  Jun Li,et al.  Supramolecular anchoring of DNA polyplexes in cyclodextrin-based polypseudorotaxane hydrogels for sustained gene delivery. , 2012, Biomacromolecules.

[2]  Yan Zhang,et al.  Self-fluorescent drug delivery vector based on genipin-crosslinked polyethylenimine conjugated globin nanoparticle. , 2017, Materials science & engineering. C, Materials for biological applications.

[3]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[4]  Thommey P. Thomas,et al.  Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent. , 2011, Bioorganic & medicinal chemistry.

[5]  C. Porter,et al.  Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability. , 2016, Angewandte Chemie.

[6]  James F Rusling,et al.  Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. , 2009, ACS nano.

[7]  W. Gradishar,et al.  Albumin-bound paclitaxel: a next-generation taxane , 2006, Expert opinion on pharmacotherapy.

[8]  O. Cummings,et al.  Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Dong Yang,et al.  Construction of polymer-paclitaxel conjugate linked via a disulfide bond. , 2016, Materials science & engineering. C, Materials for biological applications.

[10]  Zibiao Li,et al.  Role of electrostatic complementarity between perylenediimide and porphyrin in highly stabilized GNA. , 2017, Materials science & engineering. C, Materials for biological applications.

[11]  Younan Xia,et al.  A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. , 2013, ACS nano.

[12]  J. D. Obayemi,et al.  Extraction and encapsulation of prodigiosin in chitosan microspheres for targeted drug delivery. , 2017, Materials science & engineering. C, Materials for biological applications.

[13]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Peter E Wright,et al.  Structure, dynamics, and catalytic function of dihydrofolate reductase. , 2004, Annual review of biophysics and biomolecular structure.

[15]  Zibiao Li,et al.  Recent advances in stereocomplexation of enantiomeric PLA-based copolymers and applications , 2016 .

[16]  Anil K Patri,et al.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. , 2005, Advanced drug delivery reviews.

[17]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[18]  Jianbin Tang,et al.  Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy , 2013, Advanced materials.

[19]  Zibiao Li,et al.  Facile synthesis of RGD-conjugated unimolecular micelles based on a polyester dendrimer for targeting drug delivery. , 2017, Journal of materials chemistry. B.

[20]  Nico P E Vermeulen,et al.  Enzyme-Catalyzed Activation of Anticancer Prodrugs , 2004, Pharmacological Reviews.

[21]  M. Hashida,et al.  Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Jeffrey J Hanson,et al.  A photochemical approach for controlled drug release in targeted drug delivery. , 2012, Bioorganic & medicinal chemistry.

[23]  R. Głowacki,et al.  Determination of endogenous thiols and thiol drugs in urine by HPLC with ultraviolet detection. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  Zibiao Li,et al.  Towards the development of polycaprolactone based amphiphilic block copolymers: molecular design, self-assembly and biomedical applications. , 2014, Materials science & engineering. C, Materials for biological applications.

[25]  Guorui Jin,et al.  Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries. , 2016, ACS applied materials & interfaces.

[26]  P. C. Sharma,et al.  Synthesis, characterization and evaluation of prodrugs of ciprofloxacin clubbed with benzothiazoles through N-Mannich base approach , 2016 .

[27]  Thommey P. Thomas,et al.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice. , 2005, Journal of medicinal chemistry.

[28]  Xian Jun Loh,et al.  Review of Adaptive Programmable Materials and Their Bioapplications. , 2016, ACS applied materials & interfaces.

[29]  E M Callaway,et al.  Brominated 7-hydroxycoumarin-4-ylmethyls: photolabile protecting groups with biologically useful cross-sections for two photon photolysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jun Li,et al.  Biodegradable hyperbranched amphiphilic polyurethane multiblock copolymers consisting of poly(propylene glycol), poly(ethylene glycol), and polycaprolactone as in situ thermogels. , 2012, Biomacromolecules.

[31]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[32]  Jin-Zhi Du,et al.  Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.

[33]  S. Abolmaali,et al.  Chemically crosslinked nanogels of PEGylated poly ethyleneimine (l-histidine substituted) synthesized via metal ion coordinated self-assembly for delivery of methotrexate: Cytocompatibility, cellular delivery and antitumor activity in resistant cells. , 2016, Materials science & engineering. C, Materials for biological applications.

[34]  Jianping Zhou,et al.  Redox-sensitive hyaluronic acid–paclitaxel conjugate micelles with high physical drug loading for efficient tumor therapy , 2015 .

[35]  J. Neuzil,et al.  Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity , 2003, British Journal of Cancer.

[36]  Roberto Cingolani,et al.  Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticles. , 2013, Nano letters.

[37]  Shigeo Sato,et al.  Novel hyaluronic acid-methotrexate conjugates for osteoarthritis treatment. , 2009, Bioorganic & medicinal chemistry.

[38]  V. Garsky,et al.  PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[39]  F. Masood,et al.  Polymeric nanoparticles for targeted drug delivery system for cancer therapy. , 2016, Materials science & engineering. C, Materials for biological applications.

[40]  P. Swaan,et al.  Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.

[41]  X. Loh,et al.  Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery. , 2016, Small.

[42]  Qi Liu,et al.  Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[43]  Ahmed Alouane,et al.  Self-immolative spacers: kinetic aspects, structure-property relationships, and applications. , 2015, Angewandte Chemie.

[44]  Zibiao Li,et al.  Recent Progress in Using Stereocomplexation for Enhancement of Thermal and Mechanical Property of Polylactide , 2016 .

[45]  M. Peppercorn Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development , 1984 .

[46]  Xiaofeng Chen,et al.  Acute toxicity and in vivo biodistribution of monodispersed mesoporous bioactive glass spheres in intravenously exposed mice. , 2016, Materials science & engineering. C, Materials for biological applications.

[47]  Jae Yoon Hwang,et al.  Small molecule therapeutic-loaded liposomes as therapeutic carriers: from development to clinical applications , 2016 .

[48]  F. Grynszpan,et al.  Biolabile peptidyl delivery systems toward sequential drug release , 2016, Biopolymers.

[49]  Timothy J Shaw,et al.  Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. , 2009, Small.

[50]  R. Green,et al.  Subcellular compartmentalization of glutathione: correlations with parameters of oxidative stress related to genotoxicity. , 2006, Mutagenesis.

[51]  X. Loh,et al.  Safe and efficient membrane permeabilizing polymers based on PLLA for antibacterial applications , 2016 .

[52]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[53]  H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.

[54]  W. Mark Saltzman,et al.  Biomedical Engineering: Bridging Medicine and Technology , 2015 .

[55]  V. Lagente,et al.  Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis , 2016, Bioscience reports.

[56]  Zibiao Li,et al.  Functionalization of 2D transition metal dichalcogenides for biomedical applications. , 2017, Materials science & engineering. C, Materials for biological applications.

[57]  X. Loh,et al.  Emerging Supramolecular Therapeutic Carriers Based on Host-Guest Interactions. , 2016, Chemistry, an Asian journal.

[58]  D. Shabat,et al.  Quinone-methide species, a gateway to functional molecular systems: from self-immolative dendrimers to long-wavelength fluorescent dyes. , 2014, Accounts of chemical research.

[59]  X. Loh,et al.  Water soluble polyhydroxyalkanoates: future materials for therapeutic applications. , 2015, Chemical Society reviews.

[60]  Atassi Mz,et al.  Enzymic and immunochemical properties of lysozyme. Evaluation of several amino group reversible blocking reagents. , 1970 .

[61]  Guorui Jin,et al.  Design of polyhedral oligomeric silsesquioxane (POSS) based thermo-responsive amphiphilic hybrid copolymers for thermally denatured protein protection applications , 2014 .

[62]  A. Ray,et al.  Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation. , 2010, Bioconjugate chemistry.

[63]  Angela C Cruciano,et al.  Redox-triggered contents release from liposomes. , 2008, Journal of the American Chemical Society.

[64]  S. Choi,et al.  Mechanisms of drug release in nanotherapeutic delivery systems. , 2015, Chemical reviews.

[65]  C. Evelo,et al.  No reduction of α-tocopherol quinone by glutathione in rat liver microsomes , 2001 .

[66]  X. Loh,et al.  Recent advances of using polyhydroxyalkanoate-based nanovehicles as therapeutic delivery carriers. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[67]  Thommey P. Thomas,et al.  Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio. , 2012, Biomacromolecules.

[68]  Y. Lvov,et al.  Nano-encapsulation of furosemide microcrystals for controlled drug release. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[69]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[70]  O. Farokhzad,et al.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. , 2016, Chemical reviews.

[71]  A. Zelikin,et al.  Self‐Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol‐Free Drugs , 2015, Advanced healthcare materials.

[72]  S. Silverman,et al.  DNA-Catalyzed Amide Hydrolysis. , 2016, Journal of the American Chemical Society.

[73]  R. Havel,et al.  Acid hydrolases in early and late endosome fractions from rat liver. , 1991, The Journal of biological chemistry.

[74]  S. Nguyen,et al.  Triggered release of pharmacophores from [Ni(HAsO₃)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study. , 2011, ACS nano.

[75]  T. Koch,et al.  Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera. , 2004, Journal of medicinal chemistry.

[76]  Ratchapol Jenjob,et al.  Capillary microfluidics-derived doxorubicin-containing human serum albumin microbeads for transarterial chemoembolization of hepatic cancer. , 2016, Materials science & engineering. C, Materials for biological applications.

[77]  J. Fisher,et al.  Biological effects of cobalt-chromium nanoparticles and ions on dural fibroblasts and dural epithelial cells. , 2013, Biomaterials.

[78]  G. P. Hess,et al.  Photolabile protecting groups for an acetylcholine receptor ligand. Synthesis and photochemistry of a new class of o-nitrobenzyl derivatives and their effects on receptor function. , 1986, Biochemistry.

[79]  J. Singer Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[80]  X. Loh,et al.  Recent development of unimolecular micelles as functional materials and applications , 2016 .

[81]  X. Wu,et al.  Tumor specific novel taxoid-monoclonal antibody conjugates. , 2002, Current medicinal chemistry.

[82]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[83]  R. Langer,et al.  Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX. , 2004, Bioconjugate chemistry.

[84]  S. Kuo,et al.  Self-assembled structures from PEGylated polypeptide block copolymers synthesized using a combination of ATRP, ROP, and click chemistry , 2013 .

[85]  Frank Bates,et al.  Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. , 2006, Molecular pharmaceutics.

[86]  R. Freidinger,et al.  A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo , 2000, Nature Medicine.

[87]  D. Owen,et al.  Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[88]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[89]  Glen S. Kwon,et al.  Reversibly core cross-linked polymeric micelles with pH- and reduction-sensitivities: effects of cross-linking degree on particle stability, drug release kinetics, and anti-tumor efficacy , 2014 .

[90]  S. Subramani,et al.  Peroxisome matrix and membrane protein biogenesis , 2009, IUBMB life.

[91]  Samuel I. Mattern-Schain,et al.  Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain. , 2014, Chemistry.

[92]  Yaping Li,et al.  Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. , 2011, ACS nano.

[93]  M. Moses,et al.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  Li Tang,et al.  Polylactide‐cyclosporin A nanoparticles for targeted immunosuppression , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  Fei Yu,et al.  Self‐immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[96]  V. Stella,et al.  Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics. , 2010, Journal of pharmaceutical sciences.

[97]  E. Frei,et al.  The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects , 1975, Nature.

[98]  L. Magagnin,et al.  Modulation of electrostatic interactions to improve controlled drug delivery from nanogels. , 2017, Materials science & engineering. C, Materials for biological applications.

[99]  Christian Peifer,et al.  Photoactivatable Prodrugs of Antimelanoma Agent Vemurafenib. , 2015, ACS chemical biology.

[100]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[101]  Hui Zhang,et al.  New progress and prospects: The application of nanogel in drug delivery. , 2016, Materials science & engineering. C, Materials for biological applications.

[102]  E. Simanek,et al.  Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages. , 2009, Bioconjugate chemistry.

[103]  Zhi-Jun Zhang,et al.  Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell. , 2010, Chemical communications.

[104]  M. Amiji,et al.  Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[105]  M. Coleman,et al.  Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin. , 2004, Molecular cancer therapeutics.

[106]  V. Préat,et al.  Vitamin E-based nanomedicines for anti-cancer drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[107]  R. Phillips Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs , 2016, Cancer Chemotherapy and Pharmacology.

[108]  F. Toma,et al.  Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers. , 2010, Chemical communications.

[109]  E. Sadroddiny,et al.  Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review. , 2016, Materials science & engineering. C, Materials for biological applications.

[110]  X. Jing,et al.  Targeting and anti-tumor effect of folic acid-labeled polymer–Doxorubicin conjugates with pH-sensitive hydrazone linker , 2012 .

[111]  S. Adelstein,et al.  In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase–mediated cancer diagnosis and therapy , 2006, Molecular Cancer Therapeutics.

[112]  William R Wilson,et al.  Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. , 2016, Biomaterials.

[113]  Mingwu Shen,et al.  Targeted cancer theranostics using alpha-tocopheryl succinate-conjugated multifunctional dendrimer-entrapped gold nanoparticles. , 2014, Biomaterials.